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Respiratory syncytial virus (RSV) represents an important target for vaccine development. The design of an 
effective vaccine for infants is hindered by a lack of knowledge of the nature of the protective immune response to 
RSV infection in this age group.  To understand immune mechanisms in the infant lung, we examined respiratory 
samples from infants 0-6 months with severe RSV LRI, and compared these to uninfected infants.  At the peak of 
RSV infection (but not in controls), activated macrophages (CD14+, CD16+, CD68+) and B lymphocytes (CD20+, 
IgA+, IgM+, IgG+) are prominent while dendritic cells (MHCII+), T lymphocytes and T cell associated cytokines 
(Welliver et al, 2007 J. Infect. Dis. 195:1126) are not.   In nasopharyngeal secretions, polyreactive IgG, IgM and 
IgA recognizing RSV virions and apoptotic debris were readily detected.  The presence of polyspecific local 
antibodies strongly correlated with mucosal expression of BAFF, a T-independent, B-cell activating cytokine, which 
localized in lung tissue to RSV-infected and apoptotic respiratory epithelium.  Polyspecific local antibodies were 
associated with better oxygenation at presentation.  In vitro, products of RSV infected epithelium, such as BAFF, 
TLR7 ligand, and type I IFN synergistically elicited Ig and cytokine production from cultured B lymphocytes, while 
virions alone had no such effect.  Our data suggest that in infants, innate immune factors released from RSV 
infected epithelium elicit T independent, polyspecific B cell responses which have modest protective effects. 
Perhaps the lack of antigen presentation via dendritic cells in infant respiratory tissue impedes the development of 
T-dependent responses and contributes to severe disease susceptibility in this age group.  RSV vaccine strategies 
tailored for infants should recruit and mature lung-associated macrophages and dendritic cells, in order to deliver 
antigen to elicit long-lasting, T-cell dependent immunity.  Alternatively, an RSV vaccine that promotes local innate 
B lymphocyte responses might elicit short-term protection, bridging the gap between maternal antibody protection 
and the development of mature immune responses found in older children. 
© 2009 Elsevier B.V. 
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1. Main text  
Respiratory syncytial virus (RSV) is the most important cause of severe lower respiratory infection (LRI) in 
infants.   Virtually everyone is exposed to RSV within the first two years of life, resulting in approximately 100,000 
infant hospitalizations and 400 infant deaths in the US each year, and one million deaths worldwide annually.  There 
is currently no vaccination strategy to lessen the public health burden associated with RSV LRI of infancy.   
B lymphocyte responses to RSV are thought to contribute to protection and immunopathology associated with 
primary infection.  RSV-directed serum antibodies are detected at low levels in most infants one month after 
exposure, and persist for months post infection. Antiviral antibodies are also found in nasopharyngeal secretions of 
patients with acute infection, as early as one week post infection.  The relationship between antiviral antibody 
responses and protection is unclear.  Antiviral antibody titers are low in the youngest infants, possibly predisposing 
for more severe disease in this age group.  High titer maternal antibodies are associated with protection against acute 
infection, and boosted antibody levels with re-exposure coincide with milder disease in older children.  However re-
infections with RSV are common, even in adults who have high anti-RSV antibody levels, suggesting that antiviral 
antibody is not completely protective.  In rodent models of RSV infection, T helper type 2 (Th2) lymphocyte 
responses, which favor antibody production over cytotoxic responses, were associated with RSV persistence and 
immunopathogenesis.  Clinical experience with a formalin-inactivated RSV (FI-RSV) vaccine also unfortunately 
demonstrated eosinophil and lymphocyte activation in blood and lung tissue after infection with wild type RSV, 
consistent with a Th2 skewed response. Antibodies elicited with FI-RSV vaccine were not protective and possibly 
contributed to immunopathogenesis when recipients were exposed to natural infection. 
Recently we had the opportunity to examine secretions from a cohort of infants with upper versus lower 
respiratory RSV infection (Buffalo, NY), in addition to lung tissue obtained from infants with acutely fatal RSV LRI 
(Santiago, Chile).  Although our goal was to confirm T lymphocyte contributions to severe disease, we instead 
observed that both CD4 and CD8 lymphocytes and their associated cytokines were nearly absent in RSV LRI.  Our 
observations suggested that an inadequate adaptive immune response, rather than an exaggerated one, underlies 
severe RSV LRI in humans.  However, weak T helper lymphocyte responses seemed at odds with reports of 
prominent mucosal antiviral antibody detection within days of initial RSV exposure.  For this reason we extended 
our studies to characterize B lymphocyte responses during primary RSV disease in infants. 
During primary RSV LRI, antiviral antibodies have been reported in the respiratory tract, but the source of these 
antibodies is not clear.  Mucosal antibodies may be transported from serum into lung through transudation and/or 
active transport.  Alternatively antiviral antibodies may be locally produced by B lymphocytes in lung tissue.  To 
help determine the source of antibody in RSV exposed infants, we identified B cells by immunohistochemistry 
(IHC) in a panel of lung tissues obtained from nine infants with acutely fatal RSV LRI (Santiago, Chile).  CD20+ B 
lymphocytes were abundant in lung tissue of infants with RSV LRI, and localized to alveolar and perivascular 
spaces, where RSV antigen was also prominently detected.  In contrast, CD20+ cells were nearly absent in control 
lung tissues obtained from infants who died of asphyxia.  CD4+ cells were rarely identified in either RSV LRI or 
control lung tissues, as previously observed.  In RSV LRI, the lung associated B lymphocyte population included 
plasma cells, based on strong cytoplasmic detection of IgA, IgG and IgM, while almost no IgA, IgG, or IgM was 
detected in age-matched control lung tissue.  
Because a vigorous B lymphocyte response was apparent in lung tissue of infants with acute RSV LRI, while T 
lymphocytes were rare, we considered the possibility of T independent B lymphocyte antibody production.  We 
therefore examined lung tissue for expression of B cell stimulating factors by IHC.  Strong expression of CD40-L 
related factors BAFF and APRIL was observed in bronchiolar epithelium of RSV exposed infants, but not lung 
tissue of uninfected infants.  Both BAFF and APRIL have been implicated in CD40 independent Ig production and 
class switching.  Similarly, vasoactive intestinal peptide (VIP), which has also been implicated in T-independent B 
lymphocyte activation, was detected in lung epithelium of infants with RSV LRI and not in control lung tissue.  
Epithelial detection of VIP, BAFF and APRIL coincided with RSV antigen along and type I interferon induced 
proteins OAS-1 and and MxA.  Together these data suggest that RSV infected respiratory epithelium is a potentially 
important source of B cell directed factors.  
To further evaluate primary antiviral antibody responses, nasopharyngeal secretions (NPS) from 33 surviving 
infants with acute LRI (22 RSV, 10 influenza, 1 adenovirus) were collected for analysis.  As has been previously 
reported, IgA, IgG and IgM antibodies reactive with RSV antigens were robustly detected in secretions of most 
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infants with LRI at the time of presentation, and were significantly correlated with total Ig.   Infants presenting with 
RSV LRI had significantly greater RSV directed IgM and RSV directed IgA compared with infants with non-RSV 
LRI.  However, RSV-directed Ig was also detected in influenza and adenovirus LRI cases.  Because virtually all 
infants have been exposed to RSV prior to age 2, the observation of anti-RSV antibodies in infants presenting with 
influenza or adenovirus infection could reflect previous RSV experience.  In fact we did identify one infant 
presenting with influenza LRI who had received outpatient care for RSV LRI one week previously.  However, 
another possibility is that respiratory antibodies are poorly diversified and polyspecific.  Respiratory infection is 
associated with the accumulation of apoptotic epithelial cell debris and the release of replicative viral intermediates.  
We hypothesized that such debris, laden with pathogen associated molecular patterns (PAMPs), presents shared 
epitopes associated with highly conserved intracellular structures such as nucleic acids, nucleosomes, and 
virosomes.  To address the question of polyspecific antibody production, we tested the nasopharyngeal aspirates for 
reactivity with a preparation of human nuclear and nucleosomal antigens, derived from apoptotic U937 cells.  Ig 
reactive with nuclear and nucleosomal antigens of apoptotic cells was present in NPS, with IgA detection greater 
than IgG or IgM.  However no reactivity was observed against BSA or a lysate prepared from uninfected Hep-2 
cells, the cell line in which the RSV antigens were prepared.  Reactivity with apoptotic epitopes was highest in 
infants with RSV LRI, compared with influenza or adenovirus LRI.  Thus the recovery of Ig reactive with apoptotic 
cell epitopes appeared to be linked to antiviral Ig recovery, raising the possibility that factors present in infected 
lung tissue might be responsible for promoting both. 
We next attempted to clarify a role for T-dependent versus T-independent processes in the generation of total, 
RSV-directed, or anti-nuclear/nucleosomal antibodies recovered from infant NPS.  T lymphocyte associated 
cytokines including IL-2, IL-4, and IL-10 have been implicated in CD40-dependent immunoglobulin secretion and 
class switch to the IgA isotype.  Low levels of IL-2 (mean 33.7±7.2 pg/ml), IL-4 (mean 59.4±11.3 pg/ml), and IL-10 
(mean 50.5±9.3 pg/ml) were detected in most secretions analyzed.  IL-4 positively correlated with RSV-specific and 
anti-nuclear/nucleosomal IgA, but no other immunoglobulin measures.  IL-2 also tracked with higher RSV-specific 
and anti-nuclear/nucleosomal IgA although these relationships failed to reach statistical significance.  On the other 
hand, IL-10 predicted higher levels of total immunoglobulin recovery.  IL-10 was associated with higher RSV IgG, 
but did not correlate with RSV specific IgM or IgA, or with anti-nuclear/nucleosomal antibody levels.   
In contrast with the low levels of T lymphocyte dependent cytokines observed in NPS, we recovered higher 
quantities of VIP (5201.8±1559.4 pg/ml), BAFF (108.0 ±20.9 pg/ml) and APRIL (1518±635.4 pg/ml) in most NPS 
samples.  The strongest predictors of mucosal Ig were VIP and BAFF, both of which also correlated with IL-10 
recovery.  APRIL was strongly correlated with RSV-directed and anti-nuclear/nucleosomal IgA, and also predicted 
RSV-directed IgM.  Surprisingly, APRIL alone positively correlated with better oxygen saturation at the time of 
presentation, suggesting a protective role.  RSV directed IgM and IgA were associated with better oxygen 
saturation; however RSV IgG was not.  We were not able to detect IFN-α or IFN-β consistently by ELISA, but did 
observe that the interferon-induced protein CXCL10 (IP-10) was among the highest expressed cytokines in NPS of 
infants with LRI (mean 2053.8±297.5 pg/ml), perhaps consistent with type I IFN induction in lung tissue.  IFN-γ
recovery was much lower (31.4±6.0 pg/ml) and not correlated with IP-10.  Together these data suggest that innate 
immune factors, produced locally in large quantities, shape the B cell response to primary RSV infection in concert 
with IL-4.  
Both T lymphocyte-dependent and -independent stimuli may influence the mucosal antibody repertoire in infants 
with RSV LRI.  To determine how lung-localized B cells might integrate these disparate signals, we incubated 
human peripheral blood B cells with mixtures of type I IFN, TLR7 agonist imiquimod, and BAFF, along with anti-
IgM, anti-CD40, and IL-4.  As has been previously observed, B cells costimulated with type I IFN plus the TLR7 
agonist imiquimod secreted IgM, IgG, and IgA, plus IL-6 and IL-10, in a dose-dependent manner.  The addition of 
BAFF further enhanced both Ig secretion and cytokine release in the absence of T lymphocyte derived factors.  We 
found that the combination of TLR7 agonist plus type I IFN could synergize with anti-IgM, either with or without 
anti-CD40 and IL-4, to augment secretion of Ig, in the absence of T cell help.  As has been previously observed with 
influenza virus, incubation of B lymphocytes with RSV virions, either alone or in combination with anti-IgM, anti-
CD40, or IL-4, had minimal impact on immunoglobulin release.  These data indicate that innate stimuli associated 
with RSV infected cells, such as type I IFN, BAFF and TLR7 ligand, may synergize to elicit robust B cell responses 
even in the absence of T cell help. 
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T lymphocyte dependent antibody production is inefficient in infants.  Neonatal T lymphocytes exhibit deficits 
including low expression of TCR, adhesion molecules, and CD40L which result in blunted T cell help for B 
lymphocytes.  Nevertheless, an antiviral antibody response in NPS of infants is present early during primary RSV 
LRI.  In this study we observed that B lymphocytes, including plasma cells, are heavily recruited to infant lung at 
the peak of RSV illness, while CD4+ T lymphocytes were not abundant.  We also showed that B cell detection in 
tissue coincides with local expression of B cell tropic factors including BAFF, APRIL and VIP, localized primarily 
to infected respiratory epithelium.  Similarly, specific and total Ig levels in secretions of surviving infants with RSV 
LRI coincided with and correlated with BAFF, APRIL and VIP recovery, suggesting a causative relationship.  
Assuming similar disease pathogenesis in Chilean and US infants, these data implicate T lymphocyte independent 
processes in shaping the primary antiviral antibody response, in a setting where cognate T cell help is suboptimal. 
Previous studies have focused on the DC as the prime regulator of antiviral Ig responses in adult systems, either 
indirectly through T cell stimulation, or through IFN-dependent release of IL-6 and BAFF.  DCs obtained from 
infants exhibit multiple deficiencies, including limited responses to in vitro stimuli, and low expression of MHC 
class II and costimulatory molecules.  Thus while mature DCs can clearly make enormous contributions to B cell 
activation and Ig production, it is unclear whether immature DCs in infants can play this role.  Most studies which 
implicate DCs in antibody production measure serum levels of Ig.  In fact, in infants younger than six months, serum 
IgM and IgA responses to RSV are almost undetectable during the first month, while the antibody response in 
secretions appears within days and is similar qualitatively and quantitatively in infants and older children with acute 
RSV LRI.  This dissociation between mucosal and systemic Ig responses in infants may highlight a differential role 
for DCs in these two anatomic sites.  In the context of inefficient DC function, local epithelium may provide an 
alternative source of B lymphocyte directed stimuli to maintain mucosal antibody levels.  In support of this point, 
recent in vitro studies show that RSV infection of respiratory epithelial cells results in TLR3 activation, IFN-β
release, and IFN-β dependent BAFF and APRIL expression in cultured respiratory epithelium.  Our data confirm 
prominent epithelial expression of VIP, BAFF and APRIL in vivo during RSV LRI.  Colocalization of IFN-induced 
proteins such as MxA and OAS in RSV infected alveolar epithelium, and high levels of CXCL10 in NPS, imply that 
type I IFN is probably also locally expressed.  Together, these data point to RSV infected epithelium as an important 
source of innate immune factors, particularly during uncontrolled respiratory infection, and suggest that these 
cytokines may be sufficient to induce T lymphocyte independent antibody production if DC functions are immature.   
BAFF and APRIL overexpression have been previously implicated in the generation of self-reactive antibodies in 
patients with autoimmune disease.  Here we report antibodies reactive with apoptotic cell epitopes in NPS during 
primary RSV LRI.  Anti-nuclear/nucleosomal antibodies in NPS were strongly correlated to BAFF and APRIL, 
suggesting that similar mechanisms of B lymphocyte activation could be present in SLE and infant respiratory 
infection.  In acute RSV LRI, airways are occluded with dense apoptotic cellular debris, arising from massive 
infection of respiratory epithelium. Accumulation of apoptotic cellular debris is also a cardinal feature of SLE, in 
which a failure in macrophage clearance of debris is implicated in pathogenesis.  The generation of antibodies 
recognizing cellular debris may be a conserved, protective response.  Autoreactive antibodies are proposed to have a 
beneficial role in removing immune-stimulating components of dying cells, thus avoiding inflammatory cell 
recruitment and tissue destruction.  Supporting this idea, APRIL and anti-nuclear/nucleosomal antibodies of IgA 
isotype were associated with better oxygen saturation values in this cohort of infants with bronchiolitis, suggesting a 
role for APRIL and/or APRIL induced IgA in providing some degree of protection in air exchange tissue.   IgA is 
thought to provide anti-inflammatory and tolerizing signals in the mucosa, and may antagonize pro-inflammatory 
actions of IgG such as DC maturation.  The ability to generate local polyspecific IgA may facilitate the clearance of 
cellular debris without augmenting inflammation, preserving lung tissue and respiratory function. 
Together these data provide some insight into the challenges associated with an RSV vaccination approach for 
infants.  In hospitalized infants, the T cell response to RSV is blunted, and mucosal antibody response to RSV 
appears linked to factors elaborated by infected epithelial cells.  Thus, antiviral responses are initiating too late, after 
virus has already established a foothold in respiratory tissue.  Novel adjuvant strategies, in which T cell -
independent and -dependent stimuli work in synergy to optimally stimulate lung-associated B lymphocytes, may 
enhance locally-administered vaccines.  Alternatively attenuated live viruses may be utilized to stimulate sentinel 
macrophages and DCs in neonates, and trigger more prompt T and B lymphocyte collaboration after wild type virus 
challenge.  Engaging the unique contributions of both innate and adaptive antiviral responses may be required for a 
successful RSV vaccine in neonates. 
